Stabilise membrane proteins

By External Press Release Author
Tuesday, 16 September, 2008


The new MembraneMax Protein Expression Kits allow researchers to rapidly produce milligrams of soluble membrane proteins that are exceptionally easy to purify. Over 50 per cent of targets in pharmaceutical drug development are membrane proteins. The MembraneMax technology uses nanolipoprotein disks to capture, fold and stabilise membrane proteins produced in a cell-free protein expression system. In initial performance testing, over 30 human membrane proteins were expressed at >0.1mg/ml in soluble form using the new kits. MembraneMax Protein Expression Kits will be a welcome addition to the tools available to membrane protein researchers struggling to understand the detailed molecular structure and function of this therapeutically important class of proteins. Invitrogen Tel: 1800 331 627 www.invitrogen.com/membranemax

Related Articles

New species of bacteria discovered in prostate cancer patients

Researchers have discovered the genetic blueprints of 18 new bacterial species in prostate cancer...

Award-winning system automates vial filling for cell therapy

Celleo's Larkem V40 — created to address one of the bottlenecks holding back cell...

Air pollutant exposure linked to glaucoma, cataracts and suicide

People who are exposed to high levels of air pollution are more likely to develop glaucoma and...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd